Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)

Mise à jour : Il y a 4 ans
Référence : NCT00430521

Femme et Homme

  • | Pays :
  • Germany
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The aim of the study is to assess the safety & immunogenicity of a pandemic influenza vaccine administered at 2 different time points. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.


Critère d'inclusion

  • Influenza

Liens